Also trades as: CDT (NASDAQ) · $vol 2M
CDTTW NASDAQ
CDT Equity Inc.
1W: -8.6%
1M: +18.2%
3M: +77.3%
YTD: +91.8%
1Y: -20.9%
$0.01
-0.00 (-0.85%)
Weekly Expected Move ±27.5%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.0M
52W Range0.005-0.02
Volume350
Avg Volume24,184
Beta1.46
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOJames Bligh
Employees4
SectorHealthcare
IndustryBiotechnology
IPO Date2022-03-28
Websitecdtequity.com
4581 Tamiami Trail North
Naples, FL 34103
US
Naples, FL 34103
US
646 491 9132
About CDT Equity Inc.
CDT Equity Inc., established in October 2021 by David Joszef Tapolczay and Freda C. Lewis-Hall, operates from its headquarters in Naples, Florida, with a core mission to advance the development and market introduction of clinical assets.
Latest News
CDT Equity Inc. (NASDAQ:CDT) Shares Shorted: Short Interest Up 467.9% in September
CDT Equity announces 1-for-25 reverse stock split
CDT Equity Inc. (NASDAQ:CDT) Short Interest Update
CDT appoints co-founder James Bligh as CEO
CDT Equity enters SAFE investment with Pep'd to expand U.S. peptide market footprint
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Olsen Ulrik K | 0 | — | 2026-04-27 | |
| Regan Andrew | A-Award | 147,401 | — | 2026-03-24 |
| Regan Andrew | C-Conversion | 147,401 | $0.00 | 2026-03-24 |
| Taylor Mark Andrew | J-Other | 51,420,358 | — | 2026-03-17 |
| Taylor Mark Andrew | J-Other | 51,161,318 | — | 2026-03-17 |